GD
NASDAQ · GDTC
CytoMed Therapeutics Limited
Healthcare · Biotechnology
$1.03
Up+$0.13 (+14.57%)
Updated Aug 24, 2026, 3:37 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 19.36M
- P/E ratio
- -5.82
- Dividend yield
- 0.00%
- 52-week range
- $0.68 – $1.39
- Volume
- 60.31K
- Avg. volume
- 120.59K
Price performance
GDTC price history
1M range · 20 trading sessions · Daily adjusted prices
GDTC closed at $1.03 after 20 trading sessions, up 14.47% for the selected period.
- Last close
- $1.03
- Period change
- +14.47%
- Period low
- $0.80
- Period high
- $1.03
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $0.8025 | $1.0301 | $0.8025 | $1.03 | 60.31K |
| Aug 20, 2026 | $0.89 | $0.899 | $0.86 | $0.899 | 5.41K |
| Aug 19, 2026 | $0.9799 | $0.9799 | $0.89 | $0.90 | 16.98K |
| Aug 18, 2026 | $0.8976 | $0.9596 | $0.8976 | $0.9396 | 4K |
| Aug 17, 2026 | $0.912 | $0.98 | $0.88 | $0.9058 | 24.48K |
| Aug 14, 2026 | $0.851 | $0.949 | $0.80 | $0.9489 | 30.46K |
| Aug 13, 2026 | $0.8001 | $0.845 | $0.80 | $0.845 | 27.84K |
| Aug 12, 2026 | $0.8428 | $0.859 | $0.7773 | $0.8085 | 14.67K |
| Aug 11, 2026 | $0.8101 | $0.8428 | $0.80 | $0.8428 | 2.74K |
| Aug 10, 2026 | $0.8201 | $0.893 | $0.80 | $0.8001 | 50.5K |
| Aug 7, 2026 | $0.875 | $0.875 | $0.8213 | $0.8213 | 3.79K |
| Aug 6, 2026 | $0.89 | $0.93 | $0.8029 | $0.8029 | 125.9K |
| Aug 5, 2026 | $0.84 | $0.95 | $0.8316 | $0.84 | 30.22K |
| Aug 4, 2026 | $0.892 | $0.892 | $0.80 | $0.8521 | 12.19K |
| Aug 3, 2026 | $0.92 | $0.96 | $0.8787 | $0.9192 | 6.36K |
| Jul 31, 2026 | $0.95 | $0.98 | $0.93 | $0.9301 | 26.74K |
| Jul 30, 2026 | $0.91 | $0.9894 | $0.91 | $0.9894 | 9.49K |
| Jul 29, 2026 | $0.879 | $0.9986 | $0.8706 | $0.91 | 18.93K |
| Jul 28, 2026 | $0.8998 | $1.15 | $0.7103 | $0.9051 | 443.76K |
| Jul 27, 2026 | $0.948 | $0.948 | $0.82 | $0.8998 | 189.25K |
Latest GDTC news
The latest Smart Investors Daily articles mentioning GDTC.
Stock researchResearch & News · SEC Filings
Loading stock research…
